Plasma homocysteine is decreased in the hypothyroid rat

Can J Physiol Pharmacol. 2000 Jul;78(7):565-70.

Abstract

Recent clinical studies have indicated that plasma homocysteine was significantly increased in hypothyroid patients. Since hyperhomocysteinemia is an independent risk factor for cardiovascular disease we investigated homocysteine metabolism in hypothyroid rats. Hypothyroidism was induced in one study by addition of propylthiouracil (PTU) to the drinking water for 2 weeks. In a second study, thyroidectomized and sham-operated rats were used with thyroid hormone replacement via mini-osmotic pumps. Unlike the human hypothyroid patients, both groups of hypothyroid rats exhibited decreased total plasma homocysteine (30% in PTU rats, 50% in thyroidectomized rats) versus their respective controls. Thyroid replacement normalised homocysteine levels in the thyroidectomized rat. Increased activities of the hepatic trans-sulfuration enzymes were found in both models of hypothyroidism. These results provide a possible explanation for the decreased plasma homocysteine concentrations. The hypothyroid rat cannot be used as a model to study homocysteine metabolism in hypothyroid patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cystathionine beta-Synthase / physiology
  • Homocysteine / blood*
  • Hypothyroidism / blood*
  • Male
  • Propylthiouracil / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Thyroidectomy

Substances

  • Homocysteine
  • Propylthiouracil
  • Cystathionine beta-Synthase